BACKGROUND: Neuropeptide Y (NPY), a peptide neurotransmitter that regulates stress and anxiety, has been proposed to be a stress resilience factor in humans. Posttraumatic stress disorder (PTSD) is a stress-related anxiety disorder. We hypothesized that central nervous system NPY is dysregulated in PTSD and sought to redress the absence of central NPY data in the disorder. METHODS: We determined morning NPY concentrations in cerebrospinal fluid (CSF) from 10 male subjects with chronic combat-related PTSD and from 13 healthy men. Neuropeptide Y-like immunoreactivity was measured by enzyme immunoassay (EIA). RESULTS: As compared with the normal comparison subjects, PTSD patients had significantly lower concentrations of CSF neuropeptide Y (mean CSF NPY was 360.0 +/- 17.7 pg/mL in control subjects but only 233.6 +/- 28.7 pg/mL in PTSD patients [p = .0008]). Adjustments for age and body mass index (BMI) still revealed a highly significant reduction in CSF NPY in the PTSD group (p = .003). CONCLUSIONS: Men with combat-related PTSD have low CSF concentrations of the putative resiliency hormone NPY, possibly related to the disorder or to extreme stress exposure per se.
BACKGROUND:Neuropeptide Y (NPY), a peptide neurotransmitter that regulates stress and anxiety, has been proposed to be a stress resilience factor in humans. Posttraumatic stress disorder (PTSD) is a stress-related anxiety disorder. We hypothesized that central nervous system NPY is dysregulated in PTSD and sought to redress the absence of central NPY data in the disorder. METHODS: We determined morning NPY concentrations in cerebrospinal fluid (CSF) from 10 male subjects with chronic combat-related PTSD and from 13 healthy men. Neuropeptide Y-like immunoreactivity was measured by enzyme immunoassay (EIA). RESULTS: As compared with the normal comparison subjects, PTSDpatients had significantly lower concentrations of CSF neuropeptide Y (mean CSF NPY was 360.0 +/- 17.7 pg/mL in control subjects but only 233.6 +/- 28.7 pg/mL in PTSDpatients [p = .0008]). Adjustments for age and body mass index (BMI) still revealed a highly significant reduction in CSF NPY in the PTSD group (p = .003). CONCLUSIONS:Men with combat-related PTSD have low CSF concentrations of the putative resiliency hormone NPY, possibly related to the disorder or to extreme stress exposure per se.
Authors: C A Morgan; S Wang; S M Southwick; A Rasmusson; G Hazlett; R L Hauger; D S Charney Journal: Biol Psychiatry Date: 2000-05-15 Impact factor: 13.382
Authors: D G Baker; S A West; W E Nicholson; N N Ekhator; J W Kasckow; K K Hill; A B Bruce; D N Orth; T D Geracioti Journal: Am J Psychiatry Date: 1999-04 Impact factor: 18.112
Authors: A Thorsell; M Michalkiewicz; Y Dumont; R Quirion; L Caberlotto; R Rimondini; A A Mathé; M Heilig Journal: Proc Natl Acad Sci U S A Date: 2000-11-07 Impact factor: 11.205
Authors: Charles A Morgan; Ann M Rasmusson; Sheila Wang; Gary Hoyt; Richard L Hauger; Gary Hazlett Journal: Biol Psychiatry Date: 2002-07-15 Impact factor: 13.382
Authors: Charles A Morgan; Ann M Rasmusson; Brendon Winters; Richard L Hauger; Jeffrey Morgan; Gary Hazlett; Steven Southwick Journal: Biol Psychiatry Date: 2003-11-15 Impact factor: 13.382
Authors: Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz Journal: Neuropeptides Date: 2019-11-07 Impact factor: 3.286
Authors: James P Mackay; Maria Bompolaki; M Regina DeJoseph; Sheldon D Michaelson; Janice H Urban; William F Colmers Journal: J Neurosci Date: 2019-04-10 Impact factor: 6.167
Authors: Andrew M Poulos; Maxine Reger; Nehali Mehta; Irina Zhuravka; Sarah S Sterlace; Camille Gannam; David A Hovda; Christopher C Giza; Michael S Fanselow Journal: Biol Psychiatry Date: 2013-10-12 Impact factor: 13.382
Authors: Roger K Pitman; Ann M Rasmusson; Karestan C Koenen; Lisa M Shin; Scott P Orr; Mark W Gilbertson; Mohammed R Milad; Israel Liberzon Journal: Nat Rev Neurosci Date: 2012-10-10 Impact factor: 34.870